Webinar Date and Time: TO BE DETERMINED
Cytokine release syndrome (CRS) is a side effect of treatment with novel immunotherapies including bispecific antibodies and CAR T-cell therapy. CRS is caused by a large rapid release of inflammatory molecules called cytokines into the blood stream. Symptoms can range from mild and flu-like symptoms, to more severe and life-threatening. In this webinar, an overview will be provided of what CRS is, when it can occur during lymphoma treatment and how it is managed in a clinical setting.
Speaker: Dr. Michael Crump
Dr. Michael Crump
Michael Crump is a hematologist in the Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre, and Professor of Medicine at the University of Toronto. His clinical and research interests are primary and second line therapy of lymphoid malignancies, investigation of novel therapies and in autologous stem cell transplantation. He is currently the Co-Chair of the Hematology Disease Site Group and the Lymphoma Working Group Chair for the Canadian Cancer Trials Group.